Eternal

We’re proud to announce that Eternal is a finalist in the #XPRIZEFeedTheNextBillion competition. We’re thrilled to advance to the finals stage and help create new pathways for environmentally sustainable alternative chicken products to meet consumer demand. Learn more about XPRIZE Feed the Next Billion here. https://lnkd.in/gmDFgPp

“XPRIZE helped us push our ambition and try to reach a global scale.” - #XPRIZEFeedTheNextBillion finalist Eternal As we get ready for XPRIZE Feed the Next Billion finals, learn how biotechnology company Eternal democratizes access to protein around the world through their alternative chicken breast made primarily from their specialized base product: Mycofood. Mycofood is an animal-free biomass developed from nutrient-rich Fusarium venenatum–an FDA and EFSA-approved fungus. By using analytic AI and microprotein cultivation technology, Eternal has made many strides with their technology including accelerating research, optimizing production, and reducing land usage compared to traditional chicken farming by 89%. Learn more about their work here. https://lnkd.in/gwrkiyVW

Starting the long journey home from FFT gives me time to reflect on what I saw and learned. It was great to hear so many of the largest organisations, both CPG and Food Service talk about the importance of Positive Nutrition. It’s not enough to take the bad stuff out, we need to put the good stuff in which is a a great opportunity for Eternal What really struck me though was the amount and variation of companies developing new foods via fermentation, and the consensus around the lack of scale up and full scale CDMO infrastructure. There was genuine excitement when I shared the plans and capabilities of Synbio and Immensa! If I missed you at the show but you want to learn more about either get in touch.

Amazing event at MISTA tonight, so many inspirational people trying to change our food system for the better. I really should have done more science in school.

Mark your calendars we'll be at Future Future Food-Tech in San Francisco on March 21-22. Our own Mark Fielding will be joining a panel to discuss how life-cycle assessment will pioneer the future of alternative proteins, learn more here. https://lnkd.in/g_VY65V @XPRIZE #XPRIZEFeedTheNextBillion